Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Argan (AGX) over the last 15 years, with Q4 2025 value amounting to $117.4 million.

  • Argan's Short-term Investments fell 568.64% to $117.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $117.4 million, marking a year-over-year decrease of 568.64%. This contributed to the annual value of $153.1 million for FY2025, which is 3985.79% up from last year.
  • Per Argan's latest filing, its Short-term Investments stood at $117.4 million for Q4 2025, which was down 568.64% from $97.7 million recorded in Q3 2025.
  • Over the past 5 years, Argan's Short-term Investments peaked at $175.6 million during Q3 2022, and registered a low of $40.1 million during Q3 2021.
  • Moreover, its 5-year median value for Short-term Investments was $102.9 million (2023), whereas its average is $109.2 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first soared by 33839.51% in 2022, then tumbled by 5352.85% in 2023.
  • Quarter analysis of 5 years shows Argan's Short-term Investments stood at $90.0 million in 2021, then surged by 67.29% to $150.6 million in 2022, then fell by 28.25% to $108.0 million in 2023, then grew by 15.24% to $124.5 million in 2024, then dropped by 5.69% to $117.4 million in 2025.
  • Its Short-term Investments stands at $117.4 million for Q4 2025, versus $97.7 million for Q3 2025 and $115.0 million for Q2 2025.